vs
Tonix Pharmaceuticals Holding Corp.（TNXP）与VerifyMe, Inc.（VRME）财务数据对比。点击上方公司名可切换其他公司
Tonix Pharmaceuticals Holding Corp.的季度营收约是VerifyMe, Inc.的1.1倍（$5.4M vs $5.0M），VerifyMe, Inc.净利率更高（-66.7% vs -870.3%，领先803.6%），Tonix Pharmaceuticals Holding Corp.同比增速更快（108.8% vs -7.4%），过去两年Tonix Pharmaceuticals Holding Corp.的营收复合增速更高（47.4% vs -5.2%）
Tonix Pharmaceuticals是一家总部位于美国新泽西州查塔姆的制药企业，核心业务聚焦于中枢神经系统疾病适应症的再利用药物开发，截至2020年，该公司同时还在开展新冠疫苗研发以及一个生物防御相关项目。
VerifyMe, Inc.是一家专注于身份核验、防伪溯源及品牌保护服务的科技企业，为消费品、制药、零售等行业客户提供安全认证工具、全链路溯源系统与用户互动解决方案，业务覆盖北美及多个海外市场。
TNXP vs VRME — 直观对比
营收规模更大
TNXP
是对方的1.1倍
$5.0M
营收增速更快
TNXP
高出116.1%
-7.4%
净利率更高
VRME
高出803.6%
-870.3%
两年增速更快
TNXP
近两年复合增速
-5.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.4M | $5.0M |
| 净利润 | $-46.9M | $-3.4M |
| 毛利率 | 80.4% | 41.2% |
| 营业利润率 | -895.8% | -68.2% |
| 净利率 | -870.3% | -66.7% |
| 营收同比 | 108.8% | -7.4% |
| 净利润同比 | -112.2% | -38.4% |
| 每股收益（稀释后） | $-4.28 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TNXPVRME
| Q4 25 | $5.4M | — | ||
| Q3 25 | $3.3M | $5.0M | ||
| Q2 25 | $2.0M | $4.5M | ||
| Q1 25 | $2.4M | $4.5M | ||
| Q4 24 | $2.6M | — | ||
| Q3 24 | $2.8M | $5.4M | ||
| Q2 24 | $2.2M | $5.4M | ||
| Q1 24 | $2.5M | $5.8M |
净利润TNXPVRME
| Q4 25 | $-46.9M | — | ||
| Q3 25 | $-32.0M | $-3.4M | ||
| Q2 25 | $-28.3M | $-291.0K | ||
| Q1 25 | $-16.8M | $-571.0K | ||
| Q4 24 | $-22.1M | — | ||
| Q3 24 | $-14.2M | $-2.4M | ||
| Q2 24 | $-78.8M | $-346.0K | ||
| Q1 24 | $-14.9M | $-553.0K |
毛利率TNXPVRME
| Q4 25 | 80.4% | — | ||
| Q3 25 | 58.4% | 41.2% | ||
| Q2 25 | -63.8% | 35.2% | ||
| Q1 25 | 61.2% | 33.4% | ||
| Q4 24 | 54.2% | — | ||
| Q3 24 | 44.9% | 34.9% | ||
| Q2 24 | -52.5% | 39.1% | ||
| Q1 24 | 33.1% | 39.2% |
营业利润率TNXPVRME
| Q4 25 | -895.8% | — | ||
| Q3 25 | -1005.1% | -68.2% | ||
| Q2 25 | -1416.2% | -7.1% | ||
| Q1 25 | -660.9% | -13.3% | ||
| Q4 24 | -870.6% | — | ||
| Q3 24 | -551.2% | -52.8% | ||
| Q2 24 | -3501.6% | -10.0% | ||
| Q1 24 | -860.2% | -11.2% |
净利率TNXPVRME
| Q4 25 | -870.3% | — | ||
| Q3 25 | -972.9% | -66.7% | ||
| Q2 25 | -1415.0% | -6.4% | ||
| Q1 25 | -692.8% | -12.8% | ||
| Q4 24 | -856.2% | — | ||
| Q3 24 | -503.6% | -44.6% | ||
| Q2 24 | -3567.8% | -6.5% | ||
| Q1 24 | -601.9% | -9.6% |
每股收益（稀释后）TNXPVRME
| Q4 25 | $-4.28 | — | ||
| Q3 25 | $-3.59 | $-0.26 | ||
| Q2 25 | $-3.86 | $-0.02 | ||
| Q1 25 | $-2.84 | $-0.05 | ||
| Q4 24 | $2302.65 | — | ||
| Q3 24 | $-22.68 | $-0.23 | ||
| Q2 24 | $-1920.85 | $-0.03 | ||
| Q1 24 | $-535.72 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $207.6M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.2M | $11.1M |
| 总资产 | $277.2M | $13.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资TNXPVRME
| Q4 25 | $207.6M | — | ||
| Q3 25 | $190.1M | — | ||
| Q2 25 | $125.3M | — | ||
| Q1 25 | $131.7M | — | ||
| Q4 24 | $98.8M | — | ||
| Q3 24 | $28.2M | $2.6M | ||
| Q2 24 | $4.2M | $2.9M | ||
| Q1 24 | $7.0M | $2.8M |
总债务TNXPVRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | $9.4M | $500.0K | ||
| Q2 24 | $10.1M | $600.0K | ||
| Q1 24 | $10.8M | $800.0K |
股东权益TNXPVRME
| Q4 25 | $245.2M | — | ||
| Q3 25 | $231.1M | $11.1M | ||
| Q2 25 | $168.0M | $14.4M | ||
| Q1 25 | $180.4M | $14.6M | ||
| Q4 24 | $139.6M | — | ||
| Q3 24 | $74.2M | $10.3M | ||
| Q2 24 | $42.1M | $12.3M | ||
| Q1 24 | $108.1M | $12.4M |
总资产TNXPVRME
| Q4 25 | $277.2M | — | ||
| Q3 25 | $252.4M | $13.3M | ||
| Q2 25 | $187.4M | $17.2M | ||
| Q1 25 | $192.9M | $17.1M | ||
| Q4 24 | $162.9M | — | ||
| Q3 24 | $95.0M | $14.8M | ||
| Q2 24 | $70.3M | $17.5M | ||
| Q1 24 | $135.3M | $17.9M |
负债/权益比TNXPVRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.06× | — | ||
| Q3 24 | 0.13× | 0.05× | ||
| Q2 24 | 0.24× | 0.05× | ||
| Q1 24 | 0.10× | 0.06× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.6M | $243.0K |
| 自由现金流经营现金流 - 资本支出 | $-41.5M | — |
| 自由现金流率自由现金流/营收 | -770.4% | — |
| 资本支出强度资本支出/营收 | 34.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-103.2M | — |
8季度趋势，按日历期对齐
经营现金流TNXPVRME
| Q4 25 | $-39.6M | — | ||
| Q3 25 | $-28.8M | $243.0K | ||
| Q2 25 | $-14.8M | $710.0K | ||
| Q1 25 | $-16.6M | $-404.0K | ||
| Q4 24 | $-14.6M | — | ||
| Q3 24 | $-18.8M | $-10.0K | ||
| Q2 24 | $-9.9M | $372.0K | ||
| Q1 24 | $-17.6M | $-60.0K |
自由现金流TNXPVRME
| Q4 25 | $-41.5M | — | ||
| Q3 25 | $-29.7M | — | ||
| Q2 25 | $-15.4M | — | ||
| Q1 25 | $-16.6M | — | ||
| Q4 24 | $-14.6M | — | ||
| Q3 24 | $-18.8M | $-12.0K | ||
| Q2 24 | — | $369.0K | ||
| Q1 24 | $-17.7M | $-62.0K |
自由现金流率TNXPVRME
| Q4 25 | -770.4% | — | ||
| Q3 25 | -904.1% | — | ||
| Q2 25 | -768.8% | — | ||
| Q1 25 | -682.8% | — | ||
| Q4 24 | -566.7% | — | ||
| Q3 24 | -666.5% | -0.2% | ||
| Q2 24 | — | 6.9% | ||
| Q1 24 | -712.4% | -1.1% |
资本支出强度TNXPVRME
| Q4 25 | 34.8% | — | ||
| Q3 25 | 29.2% | — | ||
| Q2 25 | 26.4% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 4.4% | 0.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |
VRME
| Proactive Services | $4.2M | 83% |
| Other | $869.0K | 17% |
